• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Gains 1%; Exxon Mobil Posts Downbeat Earnings

    4/26/24 12:06:22 PM ET
    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Industrials
    Get the next $BDRX alert in real time by email

    U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 1% on Friday.

    The Dow traded up 0.41% to 38,243.14 while the NASDAQ rose 2.00% to 15,923.52. The S&P 500 also rose, gaining, 1.02% to 5,099.85.

    Check This Out: Top 4 Materials Stocks That May Explode In Q2

    Leading and Lagging Sectors

    Communication services shares rose by 4.1% on Friday.

    In trading on Friday, energy shares dipped by 2%.

    Top Headline

    Exxon Mobil Corporation (NYSE:XOM) reported downbeat earnings for its first quarter on Friday.

    Total revenues and other income stood at $83.083 billion, beating the consensus of $78.352 billion. Adjusted EPS stood at $2.06, missing the consensus of $2.20.

    Equities Trading UP
                           

    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares shot up 85% to $1.33 after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.
    • Shares of Focus Universal Inc. (NASDAQ:FCUV) got a boost, surging 47% to $0.4150 after the company announced board approval for the spin-off of Lusher.
    • Universal Logistics Holdings, Inc. (NASDAQ:ULH) shares were also up, gaining 31% to $43.15 after the company reported better-than-expected first-quarter financial results.

    Equities Trading DOWN

    • iClick Interactive Asia Group Limited (NASDAQ:ICLK) shares dropped 42% to $1.50 after the company announced the termination of its merger agreement.
    • Shares of Nuwellis, Inc. (NASDAQ:NUWE) were down 43% to $0.1636 after the company reported pricing of $2.7 million public offering.
    • Saia, Inc. (NASDAQ:SAIA) was down, falling 20% to $435.67 after the company reported worse-than-expected first-quarter financial results.

    Also Check This Out: How To Earn $500 A Month From Domino’s Pizza Stock Ahead Of Q1 Earnings

    Commodities

    In commodity news, oil traded down 0.1% to $83.48 while gold traded up 0.1% at $2,345.20.

    Silver traded down 0.5% to $27.21 on Friday, while copper rose 0.5% to $4.56.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 1.16%, London's FTSE 100 rose 0.76% while Spain's IBEX 35 Index rose 1.48% The German DAX rose 1.40% French CAC 40 rose 1.03% while Italy's FTSE MIB Index climbed 1.00%.

    Bank lending to households in the Eurozone rose by 0.2% year-over-year to €6.875 trillion in March. Spain’s retail trade increased by 0.6% year-over-year in March versus a revised 1.8% gain in the earlier month, while unemployment rate increased to 12.29% in the first quarter.

    The consumer confidence indicator in France declined to 90 in April versus a reading of 91 in the prior month.

    Asia Pacific Markets

    Asian markets closed mostly higher on Friday, with Japan's Nikkei 225 gaining 0.81%, Hong Kong's Hang Seng Index jumping 2.12%, China's Shanghai Composite climbing 1.17% and India's S&P BSE Sensex falling 0.82%.

    The Bank of Japan maintained its key short-term interest rate unchanged at its April meeting. Singapore’s manufacturing production declined 9.2% year-over-year in March versus a revised 4.4% increase in the prior month.

    Economics

    • The Federal Reserve's preferred measure of inflation – the Personal Consumption Expenditure (PCE) price index – rose more than expected in March. The headline PCE price index rose from 2.5% in February 2024 to 2.7% year-on-year in March, beating forecasts of a 2.6% increase, the Bureau of Economic Analysis reported Friday.
    • U.S. personal income increased by 0.5% from the prior month in March, while personal spending rose by 0.8%.
    • The University of Michigan consumer sentiment was revised lower to 77.2 in April compared to a preliminary reading of 77.9, and versus 79.4 in March.

    Now Read This: ‘I Don’t Want You To Lose Any Money’: Jim Cramer On This Industrial Stock: ‘Go Buy GE Vernova’

    Get the next $BDRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BDRX
    $FCUV
    $ICLK
    $NUWE

    CompanyDatePrice TargetRatingAnalyst
    Saia Inc.
    $SAIA
    2/11/2026$425.00Positive → Neutral
    Susquehanna
    Saia Inc.
    $SAIA
    2/10/2026$250.00Equal-Weight → Underweight
    Morgan Stanley
    Exxon Mobil Corporation
    $XOM
    2/3/2026$125.00Neutral → Underperform
    BNP Paribas Exane
    Exxon Mobil Corporation
    $XOM
    2/3/2026$135.00 → $145.00Buy
    TD Cowen
    Saia Inc.
    $SAIA
    1/13/2026Outperform → In-line
    Evercore ISI
    Saia Inc.
    $SAIA
    1/8/2026Outperform → Peer Perform
    Wolfe Research
    Saia Inc.
    $SAIA
    1/6/2026$414.00Equal-Weight → Overweight
    Stephens
    Exxon Mobil Corporation
    $XOM
    12/12/2025$128.00 → $135.00Buy
    TD Cowen
    More analyst ratings

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

    February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models Cardiff, UK – February 4, 2026 – Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with unmet medical needs, today announced the closing of an exclusive license with Otsuka Pharmaceutical Co., Ltd (Otsuka) for OPB-171775. a novel molecular glue intended to be developed for the treatment of gastrointestinal stromal tumours (GIST). The compound also has the potential to be useful

    2/4/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    ExxonMobil Announces 2025 Results

    Generated industry-leading earnings of $28.8 billion and cash flow from operations of $52.0 billion1 Delivered EPS2 of $6.70, or $6.99 excluding identified items reflecting industry-leading CAGR of 21% since 20191 Highest annual Upstream production in more than 40 years and record refinery throughput3 supported industry-leading annual shareholder distributions of $37.2 billion1 Delivered 10 of 10 key projects4; adding $3 billion of earnings on a constant price and margin basis5 Generated $15.1 billion in cumulative Structural Cost Savings since 2019, more than all other IOCs combined1 Achieved 2030 plans for Corporate greenhouse gas emissions and flaring intensity reductions

    1/30/26 6:30:00 AM ET
    $XOM
    Integrated oil Companies
    Energy

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Saia downgraded by Susquehanna with a new price target

    Susquehanna downgraded Saia from Positive to Neutral and set a new price target of $425.00

    2/11/26 7:50:53 AM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    Saia downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Saia from Equal-Weight to Underweight and set a new price target of $250.00

    2/10/26 2:29:18 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    Exxon Mobil downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Exxon Mobil from Neutral to Underperform and set a new price target of $125.00

    2/3/26 6:52:02 AM ET
    $XOM
    Integrated oil Companies
    Energy

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Field Katharyn

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:35:38 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Grasso Mika

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:31:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    EVP Operations Sugar Patrick D covered exercise/tax liability with 1,495 shares and was granted 3,101 shares, increasing direct ownership by 20% to 9,742 units (SEC Form 4)

    4 - SAIA INC (0001177702) (Issuer)

    2/10/26 4:14:30 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    SEC Filings

    View All

    Saia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SAIA INC (0001177702) (Filer)

    2/10/26 7:45:24 AM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    SEC Form EFFECT filed by Nuwellis Inc.

    EFFECT - Nuwellis, Inc. (0001506492) (Filer)

    2/10/26 12:15:32 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 424B3 filed by Nuwellis Inc.

    424B3 - Nuwellis, Inc. (0001506492) (Filer)

    2/9/26 5:22:12 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Epps Donna E bought $117,145 worth of shares (422 units at $277.60) and sold $117,075 worth of shares (422 units at $277.43) (SEC Form 4)

    4 - SAIA INC (0001177702) (Issuer)

    12/1/25 4:56:55 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    CEO and Director Wang Desheng bought $2,280 worth of shares (1,000 units at $2.28) and bought $22,260 worth of shares (10,000 units at $2.23), increasing direct ownership by 0.49% to 2,273,800 units (SEC Form 4)

    4 - FOCUS UNIVERSAL INC. (0001590418) (Issuer)

    8/15/25 6:55:39 PM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    Amendment: Director Lee Edward Shihai bought $300,000 worth of shares (1,000,000 units at $0.30), increasing direct ownership by 12% to 9,185,000 units (SEC Form 4)

    4/A - FOCUS UNIVERSAL INC. (0001590418) (Issuer)

    9/19/24 6:02:30 PM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces Changes to Board of Directors

    MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026. Ms. Field is the Chief Executive Officer of ISpecimen Inc., where she oversees performance improvement and the redevelopment of the proprietary software platform. Prior to serving as Chief Executive Officer she served as President, Chairman, and as an independent director. She has served as a director of LogProstyle since September 2024, as an Executive Director of Akanda Corporation since Ju

    1/23/26 4:40:27 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

    January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is delighted to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary along with her election to the Board of Directors of the Company with immediate effect. Ms Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistentl

    1/5/26 8:30:00 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Financials

    Live finance-specific insights

    View All

    ExxonMobil Announces 2025 Results

    Generated industry-leading earnings of $28.8 billion and cash flow from operations of $52.0 billion1 Delivered EPS2 of $6.70, or $6.99 excluding identified items reflecting industry-leading CAGR of 21% since 20191 Highest annual Upstream production in more than 40 years and record refinery throughput3 supported industry-leading annual shareholder distributions of $37.2 billion1 Delivered 10 of 10 key projects4; adding $3 billion of earnings on a constant price and margin basis5 Generated $15.1 billion in cumulative Structural Cost Savings since 2019, more than all other IOCs combined1 Achieved 2030 plans for Corporate greenhouse gas emissions and flaring intensity reductions

    1/30/26 6:30:00 AM ET
    $XOM
    Integrated oil Companies
    Energy

    ExxonMobil to Release Fourth Quarter 2025 Financial Results

    Exxon Mobil Corporation (NYSE:XOM) will release its fourth quarter 2025 financial results on Friday, January 30, 2026. The company will issue a press release via Business Wire that will be available at 5:30 a.m. CT at investor.exxonmobil.com. Darren Woods, Chairman and Chief Executive Officer; Kathy Mikells, Senior Vice President and Chief Financial Officer; Neil Hansen, incoming Senior Vice President and Chief Financial Officer (effective February 1, 2026); and Jim Chapman, Vice President, Treasurer and Investor Relations will review the results during a live conference call at 8:30 a.m. CT. The presentation will be accessible via webcast or by calling (800) 918-2066 (Toll-free) or (646)

    1/13/26 2:46:00 PM ET
    $XOM
    Integrated oil Companies
    Energy

    Saia to Announce Fourth Quarter 2025 Results on February 10, 2026

    JOHNS CREEK, Ga., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Saia, Inc. (NASDAQ:SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, announced that it will release its quarterly financial results before the market opens on Tuesday, February 10th. Saia management will host a conference call to discuss the results later that morning at 10:00 a.m. Eastern Time. To participate in the call, please dial 1-833-890-5317 and request to join the Saia, Inc. call. Callers should dial in five to ten minutes in advance of the conference call. This call will be webcast live via the company website at https://www.saia.com/abou

    12/30/25 4:30:00 PM ET
    $SAIA
    Trucking Freight/Courier Services
    Industrials

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iClick Interactive Asia Group Limited

    SC 13D/A - iClick Interactive Asia Group Ltd (0001697818) (Subject)

    12/11/24 7:11:44 AM ET
    $ICLK
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/14/24 5:12:47 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BDRX
    $FCUV
    $ICLK
    $NUWE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy